Agaimy, Abbas
Universitätsklinikum Erlangen,
Germany
2025 Rank: 9411
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 8 out of 25326 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9411 | 9049 |
| Total Cites | 1996 | 2306 |
| H-index | 17 | 18 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 34 | 34 |
| Total Cites to Single Authored Papers | 50 | 55 |
| Number of Single+First Authored Papers | 185 | 185 |
| Total Cites to Single+First Authored Papers | 551 | 607 |
| Number of Single+First+Last Authored Papers | 280 | 280 |
| Total Cites to Single+First+Last Authored Papers | 740 | 808 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1472 | 1618 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.43 |
| Self-Citation Percentage |
13.44%
|
|
Agaimy, Abbas
Friedrich-Alexander-Universität Erlangen-Nürnberg,
Germany
2024 Rank: 9234
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 10 out of 24457 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9234 | 6542 |
| Total Cites | 1864 | 2273 |
| H-index | 17 | 19 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 46 | 65 |
| Number of Single+First Authored Papers | 179 | 179 |
| Total Cites to Single+First Authored Papers | 505 | 620 |
| Number of Single+First+Last Authored Papers | 269 | 269 |
| Total Cites to Single+First+Last Authored Papers | 716 | 855 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1325 | 1469 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.55 |
| Self-Citation Percentage |
17.99%
|
|
Agaimy, Abbas
Universitätsklinikum Erlangen,
Germany
2023 Rank: 11452
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 19 out of 23576 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11452 | 8460 |
| Total Cites | 1769 | 2194 |
| H-index | 17 | 20 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 27 | 27 |
| Total Cites to Single Authored Papers | 44 | 47 |
| Number of Single+First Authored Papers | 163 | 163 |
| Total Cites to Single+First Authored Papers | 451 | 535 |
| Number of Single+First+Last Authored Papers | 245 | 245 |
| Total Cites to Single+First+Last Authored Papers | 662 | 764 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1359 | 1530 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.43 |
| Self-Citation Percentage |
19.37%
|
|
Agaimy, Abbas
Universitätsklinikum Erlangen,
Germany
2022 Rank: 9420
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 16 out of 23010 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9420 | 7531 |
| Total Cites | 1621 | 1965 |
| H-index | 17 | 19 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 23 | 23 |
| Total Cites to Single Authored Papers | 52 | 58 |
| Number of Single+First Authored Papers | 152 | 152 |
| Total Cites to Single+First Authored Papers | 445 | 526 |
| Number of Single+First+Last Authored Papers | 230 | 230 |
| Total Cites to Single+First+Last Authored Papers | 674 | 781 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1261 | 1410 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.39 |
| Self-Citation Percentage |
17.51%
|
|
Agaimy, Abbas
Universitätsklinikum Erlangen,
Germany
2021 Rank: 10114
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 20 out of 22656 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10114 | 8373 |
| Total Cites | 2221 | 2602 |
| H-index | 20 | 23 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 67 | 76 |
| Number of Single+First Authored Papers | 136 | 136 |
| Total Cites to Single+First Authored Papers | 636 | 729 |
| Number of Single+First+Last Authored Papers | 209 | 209 |
| Total Cites to Single+First+Last Authored Papers | 967 | 1095 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1745 | 1934 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.35 |
| Self-Citation Percentage |
14.64%
|
|
Agaimy, Abbas
Universitätsklinik Erlangen und Medizinische Fakultät,
Germany
2020 Rank: 13875
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 26 out of 19713 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13875 | 12465 |
| Total Cites | 1364 | 1607 |
| H-index | 16 | 18 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 18 | 18 |
| Total Cites to Single Authored Papers | 45 | 52 |
| Number of Single+First Authored Papers | 129 | 129 |
| Total Cites to Single+First Authored Papers | 439 | 490 |
| Number of Single+First+Last Authored Papers | 192 | 192 |
| Total Cites to Single+First+Last Authored Papers | 619 | 689 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1114 | 1236 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.30 |
| Self-Citation Percentage |
15.12%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.